These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative assessment of angiotensin receptor blockers in different clinical settings. Verdecchia P; Angeli F; Repaci S; Mazzotta G; Gentile G; Reboldi G Vasc Health Risk Manag; 2009; 5():939-48. PubMed ID: 19997575 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Angiotensin receptor blockers in cardiovascular disease. Maggioni AP Cardiovasc Drugs Ther; 2006 Aug; 20(4):295-308. PubMed ID: 16915347 [TBL] [Abstract][Full Text] [Related]
4. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
5. Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk. Farsang C Vasc Health Risk Manag; 2011; 7():605-22. PubMed ID: 22102784 [TBL] [Abstract][Full Text] [Related]
6. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. Verdecchia P; Gentile G; Angeli F; Reboldi G Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade. Parvanova A; Chiurchiu C; Ruggenenti P; Remuzzi G Expert Opin Pharmacother; 2005 Sep; 6(11):1931-42. PubMed ID: 16144512 [TBL] [Abstract][Full Text] [Related]
9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
10. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum]. Zeller A; Battegay E Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724 [TBL] [Abstract][Full Text] [Related]
11. Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both? Neldam S Future Cardiol; 2010 Jan; 6(1):129-35. PubMed ID: 20014992 [TBL] [Abstract][Full Text] [Related]
12. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
13. Renal protection with angiotensin receptor blockers: where do we stand. Schmieder RE; Ruilope LM; Barnett AH J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225 [TBL] [Abstract][Full Text] [Related]
15. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control. Ferrario CM Life Sci; 2010 Feb; 86(9-10):289-99. PubMed ID: 19958778 [TBL] [Abstract][Full Text] [Related]
16. The management of hypertension with angiotensin receptor blockers in special populations. Ferdinand KC; Taylor C Clin Cornerstone; 2009; 9 Suppl 3():S5-17. PubMed ID: 19409356 [TBL] [Abstract][Full Text] [Related]
17. Can the renin-angiotensin system protect against stroke? A focus on angiotensin II receptor blockers. Epstein BJ; Gums JG Pharmacotherapy; 2005 Apr; 25(4):531-9. PubMed ID: 15977915 [TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
19. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. Meredith PA Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300 [TBL] [Abstract][Full Text] [Related]